Collectively, Thr163 PSA was associated with highest metastatic tumour burden, including bone metastases, which is consistent with our observations for the behaviour of these cells in-vitro, suggestive of a relationship with the poor prognosis of the patients, carrying the rs17632542 SNP, encoding this PSA variant. Here, PROS1 is linked to neoplasm.